Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells
- 21 February 2005
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 24 (16) , 2647-2653
- https://doi.org/10.1038/sj.onc.1208246
Abstract
Vascular endothelial growth factor (VEGF) is associated with tumor angiogenesis and poor prognosis in human colorectal cancer (CRC). VEGF receptor-1 (VEGFR-1 or Flt-1) is a high-affinity receptor for VEGF and is typically considered specific to endothelial cells. Here we report the expression and function of VEGFR-1 in CRC cell lines. VEGFR-1 was expressed in all CRC cell lines studied as determined by RT–PCR, Western blot analysis, FACS, and ELISA. Treatment of the human CRC cell lines HT-29 and SW480 with VEGF-A (a ligand for both VEGFR-1 and -2) or VEGF-B (a ligand specific for VEGFR-1) led to activation of Erk-1/2, SAPK/JNK, and translocation of the p65 subunit of nuclear factor-κB into the nucleus. Both VEGF-A and -B led to significant induction of cell motility and invasiveness of CRC cells. Stimulation of cells with VEGF-A or -B also led to larger and more numerous colonies in soft agar. However, activation of VEGFR-1 did not increase CRC cell proliferation. In contrast to the previous paradigm that VEGFRs are not present on tumor cells of epithelial origin, we found that VEGFR-1 is present and functional on CRC cells, and activation by VEGF family ligands can activate processes involved in tumor progression and metastasis.Keywords
This publication has 32 references indexed in Scilit:
- A Selective and Oral Small Molecule Inhibitor of Vascular Epithelial Growth Factor Receptor (VEGFR)-2 and VEGFR-1 Inhibits Neovascularization and Vascular PermeabilityThe Journal of Pharmacology and Experimental Therapeutics, 2003
- New Approaches to the Treatment of Hepatic Malignancies Angiogenesis and Antiangiogenic Therapy of Colon Cancer Liver MetastasisAnnals of Surgical Oncology, 2003
- Angiogenesis-dependent diseasesSeminars in Oncology, 2001
- VEGF antagonistsExpert Opinion on Biological Therapy, 2001
- EXPRESSION OF THE VEGF-RECEPTOR Flt-1 IN BENIGN, PREMALIGNANT AND MALIGNANT PROSTATE TISSUESJournal of Urology, 2000
- Congenital Hereditary Lymphedema Caused by a Mutation That Inactivates VEGFR3 Tyrosine KinaseAmerican Journal of Human Genetics, 2000
- VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cellsOncogene, 1999
- The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological ActivitiesJournal of Biological Chemistry, 1996
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.The Journal of Experimental Medicine, 1994